Work

Selexipag as third add on therapy in a thalassemic patient with pulmonary hypertension

Year: 2024

Type: article

Abstract: Pulmonary Hypertension PH is a frequent clinical complication in patients with thalassemia major. PH is caused by increased pulmonary resistance induced by chronic hypoxia, iron phosphatidylserine-expressing hematologic debris, free hemoglobin, and other circulating angiotrophic factors.

Source: Open Journal of Clinical and Medical Case Reports

DOI: 10.52768/2379-1039/2309

Author: Michele Correale

Institutions: University of Foggia, Ospedali Riuniti di Foggia

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4409601773